FDA Investigator Chloe Anne K Le
Chloe Anne K Le has inspections in 1 countries as of 29 Aug 2023. Chloe Anne K Le has collaborated with a combined 1621 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
18
Last Inspection Date:
29 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Adam S Freeman,
Alice A Blair,
Andrew B Slarve,
Angel K Sandhu,
Angela D Wise,
Anna L Marroquin,
Annie H Lam,
Baker,
Blair,
Bruce D Broidy,
Capri R Woolridge,
Carr,
Chan,
Chloe Anne Leong,
Christine M Parmentier,
Cindy W Lewis,
Damon A Growl,
Daniel C Geffin,
Daniel J Roberts,
Deborah K Richardson,
Dena L Jacobs,
Edna J Hidalgo,
Edwards,
Elaine S Chow,
Elizabeth S Furukawa,
Emal Wahab,
Erica R Pomeroy,
Frank P Bianco,
Gillenwater,
Grace P Santos,
Greg K Keshishyan,
Helen J Hamaoka,
Ingrid A Zambrana,
Ismael Garibay,
James C Yee,
Jane G Choi,
Janice Wai,
Jeanne A Young,
Jennifer Crumb,
Jennifer S King,
Jessica B Darneille,
John A Liu,
Jolene S Hedgecock,
Juan A Morales,
Kacie M Crowther,
Karen D Phung,
Karen J Bak,
Karla J Gibler,
Kevin Lee,
Kevin T Gerrity,
Kimberly L Anderson,
Krystina M Jackson,
Larkin R Buckalew,
LCDR Jennifer H Rhyu,
Lee,
Leongc,
Lija V Fellows,
Linda S Shook,
Lorenzo F Edwards,
Lorraine N Williams,
LT Mark A Chen, MPH,
Macropolk,
Maida Henesian (NMI),
Makia P Dove,
Marjorie D Santos,
Mark I Nakano,
Mary C Acton,
Mcgrewp,
Megan E Kulas,
Melissa N Simanton,
Michael S Call,
Michelle L Tripp,
Nicole Yuen,
Noelani K Wu,
Nympha V Florendo,
Paula E Davis Debella,
Phung,
Quynh H Strandberg,
Rocio Guzman Velazquez,
Ronald P Boyce,
Rumany C Penn, PharmD,
Sandra S Saniga,
Sara M Richardson,
Savannah E Samp,
Sean P Desbrow,
Seema S Singh,
Sergio Chavez (NMI),
Siobhan A Gallagher,
Sondra R Davis,
State Agency,
Steven C Himebaugh,
Steven J Branch,
Stuart W Russell,
Thomas N Adjabeng,
Victoria L Morgan,
Victoria Taylor,
Wayne L Jefferson,
William J Foust,
William J Weis,
William V Millar
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more